The Fed Meeting Recap and Economic Data Review Fed Meeting Recap The Federal Reserve recently announced a 25 basis points rate hike, in line with expectations. Fed Chair Powell reiterated the central bank’s commitment to data dependency and expressed a willingness to consider all options moving forward. Despite signs of softening in the labor market,…
SEALMINER A2 Air-Cooled Rigs: A New Milestone in Bitcoin Mining The cryptocurrency market continues to evolve at an unprecedented pace, and so does the Bitcoin mining industry. Recently, our company announced the successful delivery and deployment of the first trial batch of SEALMINER A2 air-cooled rigs in our datacenters. This marks a significant step forward…
ASUS Q4 2024 Results Conference Call: Key Insights On March 11, 2025, at 4:00 AM ET, ASUSTeK Computer Inc. (ASUUY) held its Quarter 4 2024 Online Investor Conference. The event was attended by Nick Wu, the Chief Financial Officer, Hsien-Yuen Hsu and Samson Hu, both Co-Chief Executive Officers, and an unidentified company representative. In this…
Bright Green Corporation Shares Suspended from Nasdaq GRANTS, NEW MEXICO, Sept. 19, 2024 (GLOBE NEWSWIRE) — Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”), today announced that trading of its shares have been suspended from the Nasdaq Stock Exchange (“Nasdaq”) after Nasdaq cancelled the scheduled September 26, 2024 delist appeal hearing. While this…
Ripple’s Big Plans in “Uptober”! Despite the rumors of SEC’s reappeal on XRP status, Ripple is poised for exciting developments next month. Monica Long, Ripple’s president, shared insights into the company’s plans, including the upcoming RLUSD stablecoin launch, enhancements to the XRP Ledger (XRPL), and a focus on global expansion. RLUSD Stablecoin Launch Ripple’s upcoming…
Teva Pharmaceuticals and Alvotech Announce the Launch of SELARSDI™: A New Biosimilar Treatment Option Parsippany, N.J., and Reykjavík, Iceland, Feb. 21, 2025 – Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and Alvotech, a leading global biotechnology company, are pleased to announce the availability of SELARSDI™ (ustekinumab-aekn) injection in the U.S. market. This…
ADT Inc. Announces Proposed Secondary Public Offering On March 3, 2025, ADT Inc. (NYSE: ADT) made an important announcement regarding a proposed secondary public offering. The offering involves the sale of 70,000,000 shares of the Company’s common stock held by certain entities managed by affiliates of Apollo Global Management, Inc. (referred to as the “Selling…
Dividend Investing: Is ABM Industries Worth Adding to Your Portfolio? Dividends are one of the most alluring perks of being a shareholder. They offer a steady stream of passive income, providing financial security and the potential for long-term growth. However, finding a dividend stock that truly delivers requires some research and analysis. In this post,…
